Venus Medtech (Hangzhou) Inc. (VMTHF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -610.01 Million | -729.45 Million | -456.91 Million | -237 Million | -303.29 Million |
| Net Income | -735.34 Million | -1.15 Billion | -377.55 Million | -185.84 Million | -380.72 Million |
| Depreciation & Amortization | 124.78 Million | 112.35 Million | 51.62 Million | 37.71 Million | 28.21 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | 9 Million | 120.7 Million |
| Change in working capital | -117.43 Million | -142.32 Million | -146.84 Million | -139.83 Million | -79.11 Million |
| Other non-cash items | -132.89 Million | 64.83 Million | -286.62 Million | -30.49 Million | 7.62 Million |
| Investing Cash Flow | -346.85 Million | -1.07 Billion | -653.03 Million | -297.94 Million | -30.96 Million |
| Investments in PPE | -262.9 Million | -178.77 Million | -145.16 Million | -124.04 Million | -15.7 Million |
| Acquisitions | -3.54 Million | -819.82 Million | -175.66 Million | -94.13 Million | -6.44 Million |
| Investment purchases | -44.74 Million | -91.83 Million | -419.84 Million | -70.29 Million | - |
| Sales/Maturities of investments | 22.27 Million | - | 54.14 Million | - | - |
| Other Investing Activities | -86.22 Million | -88.79 Million | -446.37 Million | -193.55 Million | -8.81 Million |
| Financing Cash Flow | -173.98 Million | 635.13 Million | 1.39 Billion | 927.75 Million | 2.57 Billion |
| Debt repayment | -100.1 Million | -725.76 Million | -4.7 Million | -120 Million | -7.69 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | -72.54 Million | - | - |
| Common Stock Issuance | - | - | 1.19 Billion | 1.03 Billion | 2.67 Billion |
| Other Financing Activities | 18.04 Million | -22.74 Million | 294.83 Million | 27.49 Million | 2.58 Billion |
| Accounts receivables | 14.2 Million | -7.84 Million | -74.13 Million | -68.75 Million | -83.71 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -26.18 Million | -13.67 Million | -29.18 Million | -37.62 Million | -8.69 Million |
| Other working capital | -156.43 Million | -108.26 Million | -47.27 Million | -28.4 Million | 13.3 Million |
| Cash at beginning of period | 1.87 Billion | 2.95 Billion | 2.7 Billion | 2.41 Billion | 164.91 Million |
| Cash at end of period | 774.39 Million | 1.87 Billion | 2.95 Billion | 2.7 Billion | 2.41 Billion |
| Capital Expenditure | -262.9 Million | -178.77 Million | -145.16 Million | -124.04 Million | -15.7 Million |
| Effect of forex changes on cash | 25.82 Million | 90.8 Million | -34.4 Million | -97.88 Million | 5.24 Million |
| Net cash flow / Change in cash | -1.1 Billion | -1.07 Billion | 247.04 Million | 294.91 Million | 2.24 Billion |
| Free Cash Flow | -872.92 Million | -908.23 Million | -602.08 Million | -361.05 Million | -319 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -103.24 Million | -103.24 Million | -176.78 Million | -735.34 Million | -176.78 Million | -175.09 Million |
| Depreciation & Amortization | 29.24 Million | 29.24 Million | 34.36 Million | 124.78 Million | 31.73 Million | 28.02 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 126.89 Million | 126.89 Million | -50.81 Million | -117.43 Million | -50.81 Million | -33.38 Million |
| Other non-cash items | -11.77 Million | -11.77 Million | 53.88 Million | -132.89 Million | 56.51 Million | 14.79 Million |
| Investing Cash Flow | -18.56 Million | -18.56 Million | -156.55 Million | -346.85 Million | -156.55 Million | -16.87 Million |
| Investments in PPE | -21.77 Million | -21.77 Million | -103.67 Million | -262.9 Million | -103.67 Million | -26.64 Million |
| Acquisitions | - | - | - | -3.54 Million | - | - |
| Investment purchases | - | - | - | -44.74 Million | - | - |
| Sales/Maturities of investments | - | - | - | 22.27 Million | - | - |
| Other Investing Activities | 3.21 Million | 3.21 Million | -52.87 Million | -86.22 Million | -52.87 Million | 9.76 Million |
| Financing Cash Flow | -168.98 Million | -168.98 Million | -50.63 Million | -173.98 Million | -50.63 Million | -36.35 Million |
| Debt repayment | - | - | - | -100.1 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -168.98 Million | -168.98 Million | -50.63 Million | 18.04 Million | -50.63 Million | -36.35 Million |
| Accounts receivables | 8.26 Million | 8.26 Million | 60.73 Million | 14.2 Million | 60.73 Million | -53.63 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -5.38 Million | -5.38 Million | -6.61 Million | -26.18 Million | -6.61 Million | -6.47 Million |
| Other working capital | 124.01 Million | 124.01 Million | -104.93 Million | -156.43 Million | -104.93 Million | 26.71 Million |
| Cash at beginning of period | - | - | - | 1.87 Billion | - | - |
| Cash at end of period | -144.27 Million | -144.27 Million | -339.38 Million | 774.39 Million | -339.38 Million | -213.13 Million |
| Capital Expenditure | -21.77 Million | -21.77 Million | -103.67 Million | -262.9 Million | -103.67 Million | -26.64 Million |
| Effect of forex changes on cash | 2.14 Million | 2.14 Million | 7.15 Million | 25.82 Million | 7.15 Million | 5.75 Million |
| Net cash flow / Change in cash | -144.27 Million | -144.27 Million | -339.38 Million | -1.1 Billion | -339.38 Million | -213.13 Million |
| Free Cash Flow | 19.34 Million | 19.34 Million | -243.02 Million | -872.92 Million | -243.02 Million | -192.3 Million |
MANRIN
605319
BEYOND
ORKLF
600101
TSRYY